AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Top 26%
#1397 out of 5496 analysts
Average Return
+13.5%
Win Rate
50%12 out of 24
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +224.81% | $16.20 | $52.62 | 2025-08-07 - 2026-08-06 | Buy |
Annexon IncANNX | +116.80% | $2.44 | $5.29 | 2025-08-15 - 2026-08-14 | Buy |
Dyne Therapeutics IncDYN | +76.03% | $14.60 | $25.70 | 2026-03-03 - 2026-08-14 | Buy |
Maze Therapeutics IncMAZE | +61.51% | $17.64 | $28.49 | 2025-07-23 - 2026-07-22 | Buy |
Avidity Biosciences IncRNAM | +56.46% | $44.74 | $70.00 | 2025-09-12 - 2025-10-27 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | 5 | Buy | $70.00 | +28.42% | Maintains | 2 months ago |
Maze Therapeutics IncMAZE | 5 | Buy | $110.00 | +304.71% | Maintains | 5 months ago |
Dyne Therapeutics IncDYN | 3 | Buy | $50.00 | +94.55% | Maintains | 5 months ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $37.00 | +31.02% | Reiterates | 6 months ago |
Stoke Therapeutics IncSTOK | 1 | Buy | $50.00 | +59.90% | Maintains | 8 months ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +568.90% | Maintains | 9 months ago |
Avidity Biosciences IncRNAM | 2 | Hold | $72.00 | +388.14% | Downgrades | 10 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +421.74% | Maintains | 10 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +3,892.02% | Initiates Coverage On | a year ago |
Annexon IncANNX | 1 | Buy | $14.00 | +164.65% | Reiterates | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.